The DOI matches its Crossref record; 77 of the 77 references it cites were found in a registry or an index.
Phage Cocktails and the Future of Phage Therapy
Open accessAbstract
Viruses of bacteria, known as bacteriophages or phages, were discovered nearly 100 years ago. Their potential as antibacterial agents was appreciated almost immediately, with the first 'phage therapy' trials predating Fleming's discovery of penicillin by approximately a decade. In this review, we consider phage therapy that can be used for treating bacterial infections in humans, domestic animals and even biocontrol in foods. Following an overview of the topic, we explore the common practice - both experimental and, in certain regions of the world, clinical - of mixing therapeutic phages into cocktails consisting of multiple virus types. We conclude with a discussion of the commercial and medical context of phage cocktails as therapeutic agents. In comparing off-the-shelf versus custom approaches, we consider the merits of a middle ground, which we deem 'modifiable'. Finally, we explore a regulatory framework for such an approach based on an influenza vaccine model.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
US Environmental Protection Agency
(1998) · Choice Reviews Online · doi:10.5860/choice.35-4455 · Cited by 5,897
Bacteriophage resistance mechanisms
Labrie, S. J., Samson, J. E., & Moineau, S. (2010) · Nature Reviews Microbiology · doi:10.1038/nrmicro2315 · Cited by 2,397
Bacteriocins—A viable alternative to antibiotics?
Cotter, P. D., Ross, R. P., & Hill, C. (2013) · Nature Reviews Microbiology · doi:10.1038/nrmicro2937 · Cited by 1,793
Antibiotics for Emerging Pathogens
Fischbach, M. A., & Walsh, C. T. (2009) · Science · doi:10.1126/science.1176667 · Cited by 1,777
(2001) · Wiley eBooks · doi:10.1002/047001590x · Cited by 1,111
Evolutionary relationships among diverse bacteriophages and prophages: All the world’s a phage
Hendrix, R. W., Smith, M. C. M., Burns, R. N., Ford, M. E., & Hatfull, G. F. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.5.2192 · Cited by 1,107
Pros and cons of phage therapy
Loc-Carrillo, C., & Abedon, S. T. (2011) · Bacteriophage · doi:10.4161/bact.1.2.14590 · Cited by 1,020
Self-citationPhage treatment of human infections
Abedon, S. T., Kuhl, S. J., Blasdel, B. G., & Kutter, E. M. (2011) · Bacteriophage · doi:10.4161/bact.1.2.15845 · Cited by 980
Self-citationAN INVESTIGATION ON THE NATURE OF ULTRA-MICROSCOPIC VIRUSES.
Twort, F. W. (1915) · The Lancet · doi:10.1016/s0140-6736(01)20383-3 · Cited by 901
Molecular Biology of Bacteriophage T4
(1994) · ASM Press eBooks · doi:10.1128/ecosalplus.bacteriophage-t4 · Cited by 878
Wright, A., Hawkins, C. H., Änggård, E. E., & Harper, D. R. (2009) · Clinical Otolaryngology · doi:10.1111/j.1749-4486.2009.01973.x · Cited by 864
Bacteriophage Host Range and Bacterial Resistance
Hyman, P., & Abedon, S. T. (2010) · Advances in Applied Microbiology · doi:10.1016/s0065-2164(10)70007-1 · Cited by 819
Self-citationPhage Therapy in Clinical Practice: Treatment of Human Infections
Kutter, E., De Vos, D., Gvasalia, G., Alavidze, Z., Gogokhia, L., Kuhl, S., & Abedon, S. (2010) · Current Pharmaceutical Biotechnology · doi:10.2174/138920110790725401 · Cited by 670
Self-citationMerabishvili, M., Pirnay, J.-P., Verbeken, G., Chanishvili, N., Tediashvili, M., Lashkhi, N., Glonti, T., Krylov, V., Mast, J., Van Parys, L., et al. (2009) · PLoS ONE · doi:10.1371/journal.pone.0004944 · Cited by 511
Population and evolutionary dynamics of phage therapy
Levin, B. R., & Bull, J. J. (2004) · Nature Reviews Microbiology · doi:10.1038/nrmicro822 · Cited by 511
Phage Choice, Isolation, and Preparation for Phage Therapy
Gill, J., & Hyman, P. (2010) · Current Pharmaceutical Biotechnology · doi:10.2174/138920110790725311 · Cited by 441
Bacteriophage endolysins: A novel anti-infective to control Gram-positive pathogens
Fischetti, V. A. (2010) · International Journal of Medical Microbiology · doi:10.1016/j.ijmm.2010.04.002 · Cited by 438
Bacteriophage therapy: a revitalized therapy against bacterial infectious diseases
Matsuzaki, S., Rashel, M., Uchiyama, J., Sakurai, S., Ujihara, T., Kuroda, M., Imai, S., Ikeuchi, M., Tani, T., Fujieda, M., et al. (2005) · Journal of Infection and Chemotherapy · doi:10.1007/s10156-005-0408-9 · Cited by 409
The human microbiome: ecosystem resilience and health
Relman, D. A. (2012) · Nutrition Reviews · doi:10.1111/j.1753-4887.2012.00489.x · Cited by 383
Rea, M. C., Dobson, A., O'Sullivan, O., Crispie, F., Fouhy, F., Cotter, P. D., Shanahan, F., Kiely, B., Hill, C., & Ross, R. P. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1001224107 · Cited by 377
Clinical Aspects of Phage Therapy
Międzybrodzki, R., Borysowski, J., Weber-Dąbrowska, B., Fortuna, W., Letkiewicz, S., Szufnarowski, K., Pawełczyk, Z., Rogóż, P., Kłak, M., Wojtasik, E., et al. (2012) · Advances in Virus Research · doi:10.1016/b978-0-12-394438-2.00003-7 · Cited by 373
Bacteriophage Therapy To Reduce Campylobacter jejuni Colonization of Broiler Chickens
Loc Carrillo, C., Atterbury, R. J., El-Shibiny, A., Connerton, P. L., Dillon, E., Scott, A., & Connerton, I. F. (2005) · Applied and Environmental Microbiology · doi:10.1128/aem.71.11.6554-6563.2005 · Cited by 367
Self-citationFu, W., Forster, T., Mayer, O., Curtin, J. J., Lehman, S. M., & Donlan, R. M. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00669-09 · Cited by 362
Abuladze, T., Li, M., Menetrez, M. Y., Dean, T., Senecal, A., & Sulakvelidze, A. (2008) · Applied and Environmental Microbiology · doi:10.1128/aem.01465-08 · Cited by 353
Phage therapy: past history and future prospects.
Carlton, R. M. (1999) · PubMed · Cited by 342
Phage Therapy of Pseudomonas aeruginosa Infection in a Mouse Burn Wound Model
McVay, C. S., Velásquez, M., & Fralick, J. A. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01028-06 · Cited by 306
The Phage Therapy Paradigm: Prêt-à-Porter or Sur-mesure?
Pirnay, J.-P., De Vos, D., Verbeken, G., Merabishvili, M., Chanishvili, N., Vaneechoutte, M., Zizi, M., Laire, G., Lavigne, R., Huys, I., et al. (2011) · Pharmaceutical Research · doi:10.1007/s11095-010-0313-5 · Cited by 298
Phage therapy: Facts and fiction
Skurnik, M., & Strauch, E. (2006) · International Journal of Medical Microbiology · doi:10.1016/j.ijmm.2005.09.002 · Cited by 296
Abedon, S., & Thomas-Abedon, C. (2010) · Current Pharmaceutical Biotechnology · doi:10.2174/138920110790725410 · Cited by 284
Self-citationA Method for Generation Phage Cocktail with Great Therapeutic Potential
Gu, J., Liu, X., Li, Y., Han, W., Lei, L., Yang, Y., Zhao, H., Gao, Y., Song, J., Lu, R., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0031698 · Cited by 268
Phage as a Modulator of Immune Responses
Górski, A., Międzybrodzki, R., Borysowski, J., Dąbrowska, K., Wierzbicki, P., Ohams, M., Korczak-Kowalska, G., Olszowska-Zaremba, N., Łusiak-Szelachowska, M., Kłak, M., et al. (2012) · Advances in Virus Research · doi:10.1016/b978-0-12-394438-2.00002-5 · Cited by 266
Anany, H., Chen, W., Pelton, R., & Griffiths, M. W. (2011) · Applied and Environmental Microbiology · doi:10.1128/aem.05493-11 · Cited by 239
Alemayehu, D., Casey, P. G., McAuliffe, O., Guinane, C. M., Martin, J. G., Shanahan, F., Coffey, A., Ross, R. P., & Hill, C. (2012) · mBio · doi:10.1128/mbio.00029-12 · Cited by 231
Vaccines for Seasonal and Pandemic Influenza
Nichol, K. L., & Treanor, J. J. (2006) · The Journal of Infectious Diseases · doi:10.1086/507544 · Cited by 228
Quantitative Models of In Vitro Bacteriophage–Host Dynamics and Their Application to Phage Therapy
Cairns, B. J., Timms, A. R., Jansen, V. A. A., Connerton, I. F., & Payne, R. J. H. (2009) · PLoS Pathogens · doi:10.1371/journal.ppat.1000253 · Cited by 227
Carvalho, C. M., Gannon, B. W., Halfhide, D. E., Santos, S. B., Hayes, C. M., Roe, J. M., & Azeredo, J. (2010) · BMC Microbiology · doi:10.1186/1471-2180-10-232 · Cited by 223
Phage Therapy for Plant Disease Control
Balogh, B., Jones, J., Iriarte, F., & Momol, M. (2010) · Current Pharmaceutical Biotechnology · doi:10.2174/138920110790725302 · Cited by 220
Chan, B. K., & Abedon, S. T. (2012) · Advances in Applied Microbiology · doi:10.1016/b978-0-12-394805-2.00001-4 · Cited by 212
Self-citationBiotechnological challenges of phage therapy
Skurnik, M., Pajunen, M., & Kiljunen, S. (2007) · Biotechnology Letters · doi:10.1007/s10529-007-9346-1 · Cited by 203
Phage Therapy To Reduce Preprocessing Salmonella Infections in Market-Weight Swine
Wall, S. K., Zhang, J., Rostagno, M. H., & Ebner, P. D. (2010) · Applied and Environmental Microbiology · doi:10.1128/aem.00785-09 · Cited by 199
Filippov, A. A., Sergueev, K. V., He, Y., Huang, X.-Z., Gnade, B. T., Mueller, A. J., Fernandez-Prada, C. M., & Nikolich, M. P. (2011) · PLoS ONE · doi:10.1371/journal.pone.0025486 · Cited by 191
Hawkins, C., Harper, D., Burch, D., Änggård, E., & Soothill, J. (2010) · Veterinary Microbiology · doi:10.1016/j.vetmic.2010.05.014 · Cited by 183
Hall, A. R., De Vos, D., Friman, V.-P., Pirnay, J.-P., & Buckling, A. (2012) · Applied and Environmental Microbiology · doi:10.1128/aem.00757-12 · Cited by 180
Antibiotics and the resistant microbiome
Sommer, M. O., & Dantas, G. (2011) · Current Opinion in Microbiology · doi:10.1016/j.mib.2011.07.005 · Cited by 174
Andreatti Filho, R. L., Higgins, J. P., Higgins, S. E., Gaona, G., Wolfenden, A. D., Tellez, G., & Hargis, B. M. (2007) · Poultry Science · doi:10.1093/ps/86.9.1904 · Cited by 162
Miller, R. W., Skinner, J., Sulakvelidze, A., Mathis, G. F., & Hofacre, C. L. (2010) · Avian Diseases · doi:10.1637/8953-060509-reg.1 · Cited by 157
Viazis, S., Akhtar, M., Feirtag, J. M., & Diez‐Gonzalez, F. (2010) · Food Microbiology · doi:10.1016/j.fm.2010.09.009 · Cited by 157
Newer antibacterial drugs for a new century
Devasahayam, G., Scheld, W. M., & Hoffman, P. S. (2010) · Expert Opinion on Investigational Drugs · doi:10.1517/13543780903505092 · Cited by 155
Goodridge, L. D. (2010) · Current Pharmaceutical Biotechnology · doi:10.2174/138920110790725348 · Cited by 155
What is needed for phage therapy to become a reality in Western medicine?
Brüssow, H. (2012) · Virology · doi:10.1016/j.virol.2012.09.015 · Cited by 139
Abedon, S. T. (2011) · Advances in applied microbiology · doi:10.1016/b978-0-12-387044-5.00001-7 · Cited by 135
Self-citationPhage Therapy: Concept to Cure
Keen, E. C. (2012) · Frontiers in Microbiology · doi:10.3389/fmicb.2012.00238 · Cited by 135
Bacteriophage Treatment Reduces Salmonella Colonization of Infected Chickens
Borie, C., Albala, I., Sánchez, P., Sánchez, M. L., Ramírez, S., Navarro, C., Morales, M. A., Retamales, J., & Robeson, J. P. (2008) · Avian Diseases · doi:10.1637/8091-082007-reg · Cited by 130
T4 phages against Escherichia coli diarrhea: Potential and problems
Denou, E., Bruttin, A., Barretto, C., Ngom‐Bru, C., Brüssow, H., & Zuber, S. (2009) · Virology · doi:10.1016/j.virol.2009.03.009 · Cited by 112
Seasonal inactivated influenza virus vaccines
Couch, R. B. (2008) · Vaccine · doi:10.1016/j.vaccine.2008.05.076 · Cited by 107
Valente, R. H., Guimarães, P. R., Junqueira, M., Neves‐Ferreira, A. G. C., Soares, M. R., Chapeaurouge, A., Trugilho, M. R. O., León, I. R., da Rocha, S. B., Oliveira-Carvalho, A. L., et al. (2009) · Journal of Proteomics · doi:10.1016/j.jprot.2009.01.001 · Cited by 105
Virulent Bacteriophages Can Target O104:H4 Enteroaggregative Escherichia coli in the Mouse Intestine
Maura, D., Galtier, M., Bouguénec, C. L., & Debarbieux, L. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00602-12 · Cited by 104
Antibodies for the treatment of bacterial infections: current experience and future prospects
Bebbington, C. R., & Yarranton, G. T. (2008) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2008.10.002 · Cited by 100
Mass spectrometry‐based “omics” technologies in cancer diagnostics
Zhang, X., Wei, D., Yap, Y., Li, L., Guo, S., & Chen, F. (2007) · Mass Spectrometry Reviews · doi:10.1002/mas.20132 · Cited by 96
Immunobiology of Influenza Vaccines
Lorenzo, M. M. G., & Fenton, M. J. (2013) · CHEST Journal · doi:10.1378/chest.12-1711 · Cited by 94
Oliveira, A., Sereno, R., & Azeredo, J. (2010) · Veterinary Microbiology · doi:10.1016/j.vetmic.2010.05.015 · Cited by 94
Optimizing the European Regulatory Framework for Sustainable Bacteriophage Therapy in Human Medicine
Verbeken, G., Pirnay, J., Vos, D. D., Jennes, S., Zizi, M., Lavigne, R., Casteels, M., & Huys, I. (2012) · Archivum Immunologiae et Therapiae Experimentalis · doi:10.1007/s00005-012-0175-0 · Cited by 90
Efficacy of Bacteriophage Treatment in Murine Burn Wound Infection Induced by Klebsiella pneumoniae
Chhibber, S. (2009) · Journal of Microbiology and Biotechnology · doi:10.4014/jmb.0808.493 · Cited by 82
Fighting Antibiotic Resistance: Marrying New Financial Incentives To Meeting Public Health Goals
Kesselheim, A. S., & Outterson, K. (2010) · Health Affairs · doi:10.1377/hlthaff.2009.0439 · Cited by 73
de Kock, L. (1996) · Scrutiny2 · doi:10.1080/18125449608565872 · Cited by 70
Pouillot, F., Blois, H., & Iris, F. (2010) · Biosecurity and Bioterrorism Biodefense Strategy Practice and Science · doi:10.1089/bsp.2009.0057 · Cited by 64
Metagenomics of human microbiome: beyond 16s rDNA
Gosalbes, M. J., Abellan, J. J., Durbán, A., Pérez‐Cobas, A. E., Latorre, A., & Moyá, A. (2012) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2012.03865.x · Cited by 55
Phage Therapy: Emergent Property Pharmacology
Abedon, A. J. C. S. T. (2012) · Journal of Bioanalysis & Biomedicine · doi:10.4172/1948-593x.s6-002 · Cited by 45
Bacteriophages in health and disease
Hyman, P., & Abedon, S. T. (2012) · CABI eBooks · doi:10.1079/9781845939847.0000 · Cited by 41
Self-citationYang, N., Ginsburg, G. S., & Simmons, L. A. (2012) · Obesity Reviews · doi:10.1111/j.1467-789x.2012.01048.x · Cited by 33
In VivoGrowth Rates Are Poorly Correlated with Phage Therapy Success in a Mouse Infection Model
Bull, J. J., Otto, G., & Molineux, I. J. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.05842-11 · Cited by 32
Bacteriophages reduce Escherichia coli O157:H7 levels in experimentally inoculated sheep
Bach, S. J., Johnson, R. P., Stanford, K., & McAllister, T. A. (2009) · Canadian Journal of Animal Science · doi:10.4141/cjas08083 · Cited by 28
Bacteriophage Treatment of Burn Wound Infection Caused by Pseudomonas aeruginosa PAO in BALB/c Mice
Kumari, S., Harjai, K., & Chhibber, S. (2009) · American Journal of Biomedical Sciences · doi:10.5099/aj090400385 · Cited by 25
Personalized medicine policy challenges: measuring clinical utility at point of care
van Rooij, T., Wilson, D. M., & Marsh, S. (2012) · Expert Review of Pharmacoeconomics & Outcomes Research · doi:10.1586/erp.12.15 · Cited by 24
Phage therapy of wounds and related purulent infections.
Loc-Carrillo, C., Wu, S. J., & Beck, J. P. (2012) · CABI eBooks · doi:10.1079/9781845939847.0185 · Cited by 15
Self-citationAll the world's a phage: Viruses that eat bacteria abound—and surprise
Travis, J. P. (2003) · Science News · doi:10.2307/3982016 · Cited by 10
Cold-adapted influenza vaccines
Bradshaw, J., & Wright, P. F. (2002) · Current Opinion in Pediatrics · doi:10.1097/00008480-200202000-00017 · Cited by 8
Cited by
Emerging Strategies to Combat ESKAPE Pathogens in the Era of Antimicrobial Resistance: A Review
Mulani, M. S., Kamble, E. E., Kumkar, S. N., Tawre, M. S., & Pardesi, K. R. (2019) · Frontiers in Microbiology · doi:10.3389/fmicb.2019.00539 · Cited by 1,644
Jault, P., Leclerc, T., Jennes, S., Pirnay, J. P., Que, Y.-A., Resch, G., Rousseau, A. F., Ravat, F., Carsin, H., Le Floch, R., et al. (2019) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(18)30482-1 · Cited by 874
Resistance Development to Bacteriophages Occurring during Bacteriophage Therapy
Oechslin, F. (2018) · Viruses · doi:10.3390/v10070351 · Cited by 594
Phage on tap–a quick and efficient protocol for the preparation of bacteriophage laboratory stocks
Bonilla, N., Rojas, M. I., Netto Flores Cruz, G., Hung, S.-H., Rohwer, F., & Barr, J. J. (2016) · PeerJ · doi:10.7717/peerj.2261 · Cited by 353
Pires, D., Melo, L., Vilas Boas, D., Sillankorva, S., & Azeredo, J. (2017) · Current Opinion in Microbiology · doi:10.1016/j.mib.2017.09.004 · Cited by 312
Metadata
- Authors
- Chan, B. K., Abedon, S. T., & Loc-Carrillo, C.
- Venue
- Future Microbiology
- Publisher
- Informa UK Limited
- Published
- 2013-05-23
- Volume
- 8
- Issue
- 6
- Pages
- 769-783
- ISSN
- 1746-0913 (ISSN-L)
- 1746-0921
- OpenAlex
- W2123978130
- Cited by
- 914
- References
- 77
- FWCI
- 37.99
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.